Today, the U.S. Department of Health and Human Services (HHS) in collaboration with the Department of Defense (DOD) awarded a $481 million Other Transaction Agreement to Cue Health, Inc. to expand U.S. production capacity for a cartridge-based point-of-care COVID-19 molecular test that produces results in about 20 minutes. This partnership with HHS and DOD will allow Cue to expand its industrial base and increase domestic production to 100,000 COVID-19 test kits per day by March 2021, and demonstrate this capacity through the delivery of six million COVID-19 tests and 30,000 instruments to the U.S. Government to support the domestic COVID-19 pandemic response.

 

 

Image by Gerd Altmann from Pixabay

Read more…